Non-alcoholic fatty liver disease concerns with glucokinase activators

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)684-685
Number of pages3
JournalThe Lancet Diabetes & Endocrinology
Volume6
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Cite this